How did drinking a large glass of expensive celery juice every morning become the latest health fad? It beats us.
The FDA’s re-analysis showed essentially what we already knew. There's a huge antibiotic effect in the treatment of bacterial pneumonia. The effect is the greatest when looking at the early response to antibiotic therapy, but is still large even when looking at later cure.
Police-involved shootings, the cultural impact upon the "hard" sciences, urban planning gone awry, and stealthy enemies.
There are at least 24 different concepts of what constitutes a species. Unfortunately, politics plays a substantial role in the process.
If your sole goal in life is getting your hands on a can of Lysol spray, be prepared to be bitterly disappointed. The EPA gave its approval for Reckitt Benckiser (which sells the stuff) to make anti-COVID claims for two Lysol products. What's in there that can kill the virus? Time for "The Dreaded Chemistry Lesson From Hell"? I think so.
One of the great knocks on our healthcare system is that it emphasizes treatment over prevention. Frailty opens a window on alternate views of that distinction, and how we measure up.
The Food and Drug Administration recently published an analysis of antibiotic development looking back over the last 40 years. In addition, the paper was accompanied by a compelling editorial. These papers are well worth reading and are highly recommended for everyone, whether they're familiar with antibiotic development or not. And most notably, the hubris of the FDA analysis is astounding.
Shortness of breath, also known as dyspnea, is a patient’s subjective experience. For a long time, we thought that observable measurements, like the degree to which our blood was oxygenated, was consistent with that subjective experience. COVID-19 requires us to rethink those associations.
We have made amazing progress in the treatment of COVID-19. Two therapies – steroids and remdesivir – have already been shown to help. Those who benefit from these treatments owe thanks to patients who volunteered to participate in controlled clinical trials, and the physicians and pharmaceutical companies that lead them.
The world desperately awaits a COVID-19 vaccine, one that will stop the spread of this potentially deadly infection and hopefully allow us all to return to our pre-coronavirus lives. But there's no telling when a vaccine will be found -- if it will at all. With that, ACSH's Dr. Josh Bloom, who has decades of experience in drug discovery, believes that the best way forward for now involves use of antiviral drugs, a position he details as co-author of recent piece in the Baltimore Sun. His Op-Ed leads off our June media roundup, a compendium of news sources where ACSH has appeared over the last month.
